AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $737,000 | -57.2% | 3,510,189 | 0.0% | 0.02% | -50.0% |
| Q4 2021 | $1,720,000 | -49.0% | 3,510,189 | 0.0% | 0.04% | -53.3% |
| Q3 2021 | $3,370,000 | -27.8% | 3,510,189 | 0.0% | 0.09% | -34.3% |
| Q2 2021 | $4,669,000 | -36.0% | 3,510,189 | 0.0% | 0.14% | -46.3% |
| Q1 2021 | $7,301,000 | -27.5% | 3,510,189 | 0.0% | 0.26% | -34.1% |
| Q4 2020 | $10,074,000 | -5.6% | 3,510,189 | 0.0% | 0.39% | -12.8% |
| Q3 2020 | $10,671,000 | +9.4% | 3,510,189 | 0.0% | 0.44% | +6.0% |
| Q2 2020 | $9,758,000 | +49.5% | 3,510,189 | 0.0% | 0.42% | +18.7% |
| Q1 2020 | $6,529,000 | -25.6% | 3,510,189 | 0.0% | 0.35% | -15.6% |
| Q4 2019 | $8,775,000 | +110.1% | 3,510,189 | 0.0% | 0.42% | +95.3% |
| Q3 2019 | $4,177,000 | -17.9% | 3,510,189 | 0.0% | 0.21% | -20.4% |
| Q2 2019 | $5,090,000 | -4.0% | 3,510,189 | 0.0% | 0.27% | -12.1% |
| Q1 2019 | $5,300,000 | +160.3% | 3,510,189 | 0.0% | 0.31% | +155.0% |
| Q4 2018 | $2,036,000 | +56.7% | 3,510,189 | 0.0% | 0.12% | +60.0% |
| Q3 2018 | $1,299,000 | -24.5% | 3,510,189 | 0.0% | 0.08% | -20.2% |
| Q2 2018 | $1,720,000 | -80.9% | 3,510,189 | 0.0% | 0.09% | -82.4% |
| Q1 2018 | $9,021,000 | -4.5% | 3,510,189 | 0.0% | 0.53% | -14.4% |
| Q4 2017 | $9,442,000 | -39.7% | 3,510,189 | 0.0% | 0.62% | -38.2% |
| Q3 2017 | $15,655,000 | +18.9% | 3,510,189 | 0.0% | 1.01% | +9.2% |
| Q2 2017 | $13,163,000 | +16.8% | 3,510,189 | 0.0% | 0.92% | +14.8% |
| Q1 2017 | $11,268,000 | -43.7% | 3,510,189 | 0.0% | 0.80% | -44.9% |
| Q4 2016 | $20,008,000 | -18.3% | 3,510,189 | 0.0% | 1.46% | -17.0% |
| Q3 2016 | $24,501,000 | -8.3% | 3,510,189 | 0.0% | 1.76% | -11.6% |
| Q2 2016 | $26,713,000 | +22.5% | 3,510,189 | 0.0% | 1.99% | +24.8% |
| Q1 2016 | $21,798,000 | -36.4% | 3,510,189 | 0.0% | 1.60% | -42.6% |
| Q4 2015 | $34,260,000 | +44.8% | 3,510,189 | 0.0% | 2.78% | +32.2% |
| Q3 2015 | $23,659,000 | -21.5% | 3,510,189 | 0.0% | 2.10% | -25.5% |
| Q2 2015 | $30,153,000 | -7.3% | 3,510,189 | 0.0% | 2.83% | -2.8% |
| Q1 2015 | $32,539,000 | +51.0% | 3,510,189 | 0.0% | 2.91% | +39.5% |
| Q4 2014 | $21,553,000 | -15.9% | 3,510,189 | +0.0% | 2.08% | -23.1% |
| Q3 2014 | $25,623,000 | -16.3% | 3,509,949 | 0.0% | 2.71% | -21.9% |
| Q2 2014 | $30,607,000 | – | 3,509,949 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|